-
公开(公告)号：EP3551653A1
公开(公告)日：2019-10-16
申请号：EP17825761.4
申请日：2017-12-06
发明人： BUNK, Sebastian , MAURER, Dominik , FRITSCHE, Jens , WAGNER, Claudia , ALTEN, Leonie , HOFFGAARD, Franziska , FERBER, Mathias
IPC分类号： C07K14/725 , C12N15/09
-
122.发明公开
公开(公告)号：EP3517128A1
公开(公告)日：2019-07-31
申请号：EP19160336.4
申请日：2016-03-24
发明人： MAHR, Andrea , WEINSCHENK, Toni , SCHOOR, Oliver , FRITSCHE, Jens , Singh, Harpreet , SONG, Colette
摘要： The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
123.发明公开
公开(公告)号：EP3517127A1
公开(公告)日：2019-07-31
申请号：EP19160322.4
申请日：2016-03-24
发明人： MAHR, Andrea , WEINSCHENK, Toni , SCHOOR, Oliver , FRITSCHE, Jens , SINGH, Harpreet , SONG, Colette
摘要： The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
公开(公告)号：EP3428194A1
公开(公告)日：2019-01-16
申请号：EP18183508.3
申请日：2018-07-13
IPC分类号： C07K16/46
摘要： The present invention relates to a bispecific polypeptide molecule comprising a first polypeptide chain and a second polypeptide chain providing a binding region derived from a T cell receptor (TCR) being specific for a major histocompatibility complex (MHC)-associated peptide epitope, and a binding region derived from an antibody capable of recruiting human immune effector cells by specifically binding to a surface antigen of said cells, as well as methods of making the bispecific polypeptide molecule, and uses thereof.
-
125.发明公开
公开(公告)号：EP3416980A1
公开(公告)日：2018-12-26
申请号：EP17705891.4
申请日：2017-02-17
发明人： SCHOOR, Oliver , MAHR, Andrea , WEINSCHENK, Toni , WIEBE, Anita , FRITSCHE, Jens , SINGH, Harpreet
IPC分类号： C07K14/47
CPC分类号： A61K39/0011 , A61K2039/5158 , C07K14/4748 , C07K14/705 , C07K14/7051 , C07K14/70539 , C07K16/30 , C07K2319/33 , C12N5/0638 , C12N15/115 , C12N2310/16 , C12N2501/50 , C12Q1/6886 , C12Q2600/106 , C12Q2600/156 , C12Q2600/158 , G01N33/57492
摘要： The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
126.发明公开
公开(公告)号：EP3388077A1
公开(公告)日：2018-10-17
申请号：EP18174312.1
申请日：2016-03-24
发明人： Mahr, Andrea , Stevermann, Lea , Weinschenk, Toni , Schoor, Oliver , Fritsche, Jens , Singh, Harpreet
CPC分类号： C07K14/70539 , A61K38/00 , A61K38/06 , A61K38/08 , A61K38/1774 , A61K39/0005 , A61K39/0011 , A61K45/06 , A61K2039/5158 , A61K2039/54 , A61K2039/57 , A61K2039/572 , A61K2039/585 , C07K7/02 , C07K7/06 , C07K14/001 , C07K14/47 , C07K14/4702 , C07K14/4748 , C07K14/7051 , C07K16/18 , C07K16/2833 , C07K16/30 , C07K2317/24 , C07K2317/31 , C07K2317/34 , C07K2319/00 , C07K2319/40 , C12N5/0636 , C12N5/0638 , C12N9/6491 , C12N2501/998 , C12N2502/11 , C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , C12Y304/24 , G01N33/505 , G01N33/5088 , G01N33/566 , G01N33/56972 , G01N33/56977 , G01N2333/47 , G01N2333/70503 , G01N2333/7051 , G01N2333/70539 , G01N2500/10
摘要： The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
127.发明公开
公开(公告)号：EP3388076A1
公开(公告)日：2018-10-17
申请号：EP18174292.5
申请日：2016-03-24
发明人： Mahr, Andrea , Stevermann, Lea , Weinschenk, Toni , Schoor, Oliver , Fritsche, Jens , Singh, Harpreet
CPC分类号： C07K14/70539 , A61K38/00 , A61K38/06 , A61K38/08 , A61K38/1774 , A61K39/0005 , A61K39/0011 , A61K45/06 , A61K2039/5158 , A61K2039/54 , A61K2039/57 , A61K2039/572 , A61K2039/585 , C07K7/02 , C07K7/06 , C07K14/001 , C07K14/47 , C07K14/4702 , C07K14/4748 , C07K14/7051 , C07K16/18 , C07K16/2833 , C07K16/30 , C07K2317/24 , C07K2317/31 , C07K2317/34 , C07K2319/00 , C07K2319/40 , C12N5/0636 , C12N5/0638 , C12N9/6491 , C12N2501/998 , C12N2502/11 , C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , C12Y304/24 , G01N33/505 , G01N33/5088 , G01N33/566 , G01N33/56972 , G01N33/56977 , G01N2333/47 , G01N2333/70503 , G01N2333/7051 , G01N2333/70539 , G01N2500/10
摘要： The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
128.发明公开
公开(公告)号：EP3331900A2
公开(公告)日：2018-06-13
申请号：EP16750766.4
申请日：2016-08-05
发明人： MAHR, Andrea , WEINSCHENK, Toni , SCHOOR, Oliver , FRITSCHE, Jens , SINGH, Harpreet , MÜLLER, Phillip , LEIBOLD, Julia , GOLDFINGER, Valentina
CPC分类号： A61K39/0011 , A61K38/00 , A61K2039/5158 , A61K2039/572 , C07K14/47 , C07K14/4748 , C07K14/7051 , C07K16/30 , C07K2319/00 , C12N5/0636 , C12N15/115 , C12N2310/16 , C12Q1/6886 , C12Q2600/106 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16 , G01N33/57407 , G01N33/5748 , G01N33/6848 , G01N2570/00 , G01N2800/52
摘要： The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
129.发明公开
公开(公告)号：EP3325498A1
公开(公告)日：2018-05-30
申请号：EP16805839.4
申请日：2016-12-05
发明人： MAHR, Andrea , WEINSCHENK, Toni , SONG, Colette , SCHOOR, Oliver , FRITSCHE, Jens , SINGH, Harpreet
CPC分类号： A61K39/0011 , A61K35/17 , A61K38/00 , A61K2039/5158 , A61K2039/572 , C07K7/06 , C07K7/08 , C07K14/47 , C07K14/4748 , C07K14/705 , C07K14/7051 , C07K14/71 , C07K14/721 , C07K14/8135 , C07K16/18 , C07K16/28 , C07K16/2863 , C07K16/2869 , C07K16/30 , C07K16/38 , C07K16/40 , C07K2317/34 , C07K2317/76 , C07K2319/40 , C12N5/0636 , C12N5/0638 , C12N9/0091 , C12N9/1264 , C12N15/115 , C12N2310/16 , C12N2502/11 , C12Q1/6886 , C12Q2600/156 , C12Y116/01 , C12Y207/07031 , G01N33/57484 , G01N2333/47 , G06F19/20
摘要： The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
130.发明公开PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS 审中-公开用于免疫治疗的肽和用于产生用于胰腺癌和其他癌症的用途的方法的肽的组合和肽的组合
公开(公告)号：EP3310806A2
公开(公告)日：2018-04-25
申请号：EP16736799.4
申请日：2016-06-17
CPC分类号： C07K14/4748
摘要： The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
-
-
-
-
-
-
-
-
搜索结果
268 条记录 (耗时 0.067 秒)
